Ferri 100 Injection contains Iron Sucrose 100mg/5ml and is primarily used for the treatment of iron deficiency anemia, especially in patients with chronic kidney disease or those who cannot tolerate or absorb oral iron supplements. This injectable formulation provides a rapid and effective means of replenishing iron stores in the body, facilitating the production of hemoglobin and red blood cells. Iron Sucrose is a complex of polynuclear iron(III)-hydroxide in sucrose, which allows for controlled release of iron, minimizing free iron toxicity. Ferri 100 Injection is administered intravenously under medical supervision, ensuring precise dosing tailored to the patient’s iron requirements. It is indicated for patients with iron deficiency anemia who require parenteral iron therapy due to intolerance, poor absorption, or when oral iron is ineffective. Common side effects may include mild injection site reactions, hypotension, nausea, or dizziness, but serious adverse effects are rare when administered correctly. Ferri 100 Injection should be used cautiously in patients with hypersensitivity to iron sucrose or any component of the formulation. Regular monitoring of hemoglobin levels and iron parameters is recommended during treatment to avoid iron overload. Overall, Ferri 100 Injection is a valuable therapeutic option for managing iron deficiency anemia in clinical settings where oral iron therapy is inadequate or contraindicated.